AKASOL AG debuts on Frankfurt Stock Exchange

• Successful listing and inclusion of shares in the Prime Standard segment
• Use of net proceeds for the expansion of the Company’s production facility in
Langen, Germany, as well as for the expansion into the USA. The Company
also intends to use the proceeds for investments in additional test and
validation facilities as well as research and development.

Darmstadt, June 29, 2018 – AKASOL AG (“AKASOL”; the “Company”), a leading German manufacturer of high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, marine and stationary applications, has successfully completed its initial
public offering.
As of today, the shares of AKASOL (ISIN: DE000A2JNWZ9, WKN: A2JNWZ) are being traded on the regulated market (Prime Standard) of the Frankfurt Stock Exchange. Trading opened with an initial price of EUR 48.80. Sven Schulz, CEO of AKASOL, Dr. Curt Philipp Lorber, CFO of AKASOL, as well as the co-founders and
shareholders Felix von Borck, Stephen Raiser and Dr. Björn Eberleh rang the bell on the trading floor for the first price.
Sven Schulz, CEO of AKASOL, commented: “With the listing on the Frankfurt Stock Exchange, we celebrate a unique milestone in our history, which began almost 30 years ago at the Technical University of Darmstadt and led to the foundation of the commercial company AKASOL ten years ago. A lot of hard work went into this project and we are very happy to have taken the step onto the stock exchange floor. As a pioneer manufacturer of high-performance lithium-ion battery systems, we operate in a highly dynamic market that offers great growth potential. Our IPO now invites investors to take part in our growth story and work with us to further foster our promising and sustainable technology concept.”
CFO Dr. Curt Philipp Lorber adds: “Opening up to the capital markets provides us with new opportunities to access fresh capital, which we will use to implement our growth strategy. We have successfully achieved our goal and, as announced, have raised approx. EUR 100 million for AKASOL from the capital increase. We will invest in doubling our production capacity in Langen, Germany, and in the expansion into the US market. Furthermore, we want to invest in additional test and validation facilities as well as in our strong research and development department.” AKASOL considers itself a technology leader in the market for high-performance lithium-ion battery systems and plans to strengthen and consolidate this favorable market position following the IPO.

Citigroup and COMMERZBANK acted as Joint Global Coordinators and together with
Bankhaus Lampe as Joint Bookrunners. Lazard acted as financial adviser to AKASOL.

Contact
cometis AG, Georg Grießmann
Phone: +49 – (0)611 – 20 58 55 61 | Email: griessmann@cometis.de

About AKASOL:
AKASOL is a leading German manufacturer of high-performance lithium-ion battery systems for buses, commercial vehicles, rail vehicles, industrial vehicles, marine and stationary applications. Building on nearly 30 years of experience, AKASOL is a pioneer in developing, testing and manufacturing certified battery systems for the commercial transport sector.
Based in Germany, AKASOL operates a facility in Langen with an annual capacity of up to 300 MWh which is planned to be expanded to 600 MWh by 2020. To AKASOL’s knowledge, this is Europe’s largest production plant for commercial vehicle lithium-ion battery systems, currently capable of producing high-performance battery systems for up to 1,500 fully electric buses or up to 6,000 commercial vehicles per year, depending
on battery size.
AKASOL’s systems are manufactured to the industry standards demanded by leading OEM clients. Current clients include Daimler, a Swedish bus and truck manufacturer, Alstom, Bombardier, Rolls-Royce Power Systems (MTU Friedrichshafen) and Medatech. AKASOL boasts a technology-independent product portfolio. This allows the
Company to choose the best battery cells and battery chemistry according to the clients’ individual needs.

DISCLAIMER:
This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.
In the United Kingdom, this communication is directed only at persons who: (i) are qualified investors within the meaning of the Financial Services and Markets Act 2000 (as amended) and any relevant implementing measures and/or (ii) are outside the United Kingdom or (iii) have professional experience in matters relating to investments and fall within the definition of “investment professionals” contained in article 19 (5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or are persons falling within article 49 (2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order, or fall within another exemption to the Order (all such persons referred to in (i) to (iii) above together being referred to as “Relevant Persons”). Any person who is not a Relevant Person must not act or rely on this communication or any of its contents. Any investment or investment
activity to which this communication relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This communication is an advertisement.
This communication constitutes neither an offer to sell nor a solicitation to buy securities. The public offering (in Germany and Luxembourg) has been made solely by means of, and on the basis of, a published securities prospectus. An investment decision regarding the publicly offered securities of AKASOL AG should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from AKASOL AG, Landwehrstraße 55, 64293 Darmstadt, Germany or on https://www.akasol.com/investor-relations.
Statements contained herein may constitute “forward-looking statements.” Forwardlooking statements are generally identifiable by the use of the words “may”, “will”, “should”, “plan”, “expect”, “anticipate”, “estimate,” “believe”, “intend”, “project”, “goal” or “target” or the negative of these words or other variations on these words or comparable terminology.
Forward-looking statements are based on current expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Group´s or its industry`s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on forward-looking statements and the Group does not undertake publicly to update or revise any forward-looking statement that may be made in, whether as a result of new information, future events or otherwise.